Institutional & Family Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$10.3K Hold
72
﹤0.01% 412
2024
Q1
$9.24K Buy
72
+32
+80% +$3.81K ﹤0.01% 419
2023
Q4
$4.14K Hold
40
﹤0.01% 503
2023
Q3
$3.64K Hold
40
﹤0.01% 504
2023
Q2
$3.24K Hold
40
﹤0.01% 533
2023
Q1
$3.18K Sell
40
-30
-43% -$2.13K ﹤0.01% 523
2022
Q4
$4.74K Buy
70
+42
+150% +$2.46K ﹤0.01% 479
2022
Q3
$1K Hold
28
﹤0.01% 659
2022
Q2
$2K Hold
28
﹤0.01% 613
2022
Q1
$2K Hold
28
﹤0.01% 656
2021
Q4
$2K Sell
28
-16
-36% -$867 ﹤0.01% 676
2021
Q3
$2K Hold
44
﹤0.01% 784
2021
Q2
$2K Hold
44
﹤0.01% 831
2021
Q1
$1K Hold
44
﹤0.01% 882
2020
Q4
$2K Hold
44
﹤0.01% 778
2020
Q3
$2K Sell
44
-5,786
-99% -$193K ﹤0.01% 715
2020
Q2
$191K Buy
5,830
+30
+0.5% +$957 0.04% 178
2020
Q1
$175K Hold
5,800
0.04% 159
2019
Q4
$168K Sell
5,800
-700
-11% -$19.4K 0.04% 183
2019
Q3
$168K Hold
6,500
0.04% 171
2019
Q2
$166K Hold
6,500
0.04% 178
2019
Q1
$170K Hold
6,500
0.04% 190
2018
Q4
$150K Hold
6,500
0.03% 183
2018
Q3
$153K Hold
6,500
0.03% 219
2018
Q2
$150K Buy
6,500
+150
+2% +$3.56K 0.03% 216
2018
Q1
$156K Buy
+6,350
New +$167K 0.03% 190

Other funds holding NVO

Institutional & Family Asset Management's NVO Position: Q2 2024 in Review

Institutional & Family Asset Management held its Novo Nordisk (NVO) position steady in Q2 2024 at 72 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Institutional & Family Asset Management first reported a position in NVO in Q1 2018 and has held it in 26 quarters since. The position peaked at $191K in Q2 2020. 1,861 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Institutional & Family Asset Management held 72 shares of Novo Nordisk worth $10.3K as of Q2 2024.
  • Institutional & Family Asset Management left its Novo Nordisk share count unchanged in Q2 2024.
  • Novo Nordisk made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #412 holding.
  • Institutional & Family Asset Management first reported a position in Novo Nordisk in Q1 2018 and has held it in 26 quarters since.
  • Institutional & Family Asset Management's Novo Nordisk position peaked at $191K in Q2 2020.
  • 1,861 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.